A
Apellis Pharmaceuticals, Inc. (APLS)
16.97
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
16.97
0.00 (0.00%)
This stock has a consensus price target of $36.48 based on the ratings of 27 analysts. The high is $83.00 and the low is $18.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 18 | $ 36.48 | $ 83 |
| O’zgarish | 6.07% | 114.97% | 389.10% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-18 | 82.68% | Cantor Fitzgerald | $35 → $31 | Maintains | Overweight |
| 2026-03-13 | 82.68% | Roth Capital | $31 | Initiates Coverage On | Sell → Buy |
| 2026-03-05 | 118.03% | JP Morgan | $36 → $37 | Maintains | Overweight |
| 2026-03-05 | 17.86% | Mizuho | $19 → $20 | Maintains | Neutral |
| 2026-02-25 | 159.28% | Citigroup | $45 → $44 | Maintains | Buy |